7Baggers
 Published on: 2025-11-16 01:34:25  newser.com Sun, 16 Nov 2025 07:34:25 GMT
 Published on: 2025-11-15 17:56:44  newser.com Sat, 15 Nov 2025 23:56:44 GMT
 published on: 2025-11-15 13:33:36  newser.com Sat, 15 Nov 2025 19:33:36 GMT
 Published on: 2025-11-14 20:27:35  newser.com Sat, 15 Nov 2025 02:27:35 GMT
 Allarity reports Q3 EPS (19c) vs ($7.71) last year  TipRanks Fri, 14 Nov 2025 17:25:07 GMT
 Allarity Therapeutics's Q3 net loss narrows  MarketScreener Fri, 14 Nov 2025 14:09:48 GMT
 Allarity Therapeutics, Inc. SEC 10-Q Report  TradingView Fri, 14 Nov 2025 14:03:00 GMT
 published on: 2025-11-11 02:28:50  newser.com Tue, 11 Nov 2025 08:28:50 GMT
 exit strategy if you’re trapped in allarity therapeutics inc.  newser.com Tue, 11 Nov 2025 02:41:56 GMT
 published on: 2025-11-09 01:33:31  newser.com Sun, 09 Nov 2025 07:33:31 GMT
 published on: 2025-11-06 12:45:18  newser.com Thu, 06 Nov 2025 18:45:18 GMT
 published on: 2025-11-04 05:20:22  newser.com Tue, 04 Nov 2025 11:20:22 GMT
 published on: 2025-11-02 03:15:08  newser.com Sun, 02 Nov 2025 08:15:08 GMT
 published on: 2025-11-01 05:12:49  newser.com Sat, 01 Nov 2025 10:12:49 GMT

Allarity Therapeutics, Inc.
(NASDAQ:ALLR) 

ALLR stock logo

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is i...

Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends